Lexpos News

Pharmacy owners have until 3rd February 2026 to start the Pharmacy Quality Scheme (PQS) Antimicrobial Stewardship – Pharmacy First consultations – Clinical Audit. The audit, which is a quality criterion in the Patient safety domain of the 2025/26 PQS, requires pharmacy owners to complete a clinical audit focused on the clinical advice and consultations provided to patients [...]

The post PQS: Have you started your AMS Pharmacy First audit? appeared first on Community Pharmacy England.

Daily Express There have been media reports today in the Daily Express highlighting growing pharmacy pressures and closures across England and Wales. Figures from the Independent Pharmacies Association (IPA) indicate hundreds of pharmacies have closed, with warnings that recent tax and cost pressures are forcing many out of business. Rachel Reeves accused of pushing pharmacies [...]

The post Pharmacy pressures: tax rises are driving more closures across the country appeared first on Community Pharmacy England.

The MHRA has reviewed the warnings regarding addiction, dependence, withdrawal, and tolerance for gabapentin, pregabalin, benzodiazepines, and z-drugs. The findings (detailed in the Public Assessment Report) were that it was necessary to strengthen these warnings in the product information and on packaging to better inform healthcare professionals and patients of these known risks. Advice for [...]

The post MHRA Drug Safety Update: Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs appeared first on Community Pharmacy England.

Trade press From March 2026, a new Category will be introduced to Part VIIIA of the Drug Tariff as part of a series of drug reimbursement reforms previously proposed by the Department of Heath and Social Care (DHSC). Products will begin to move into Category H, from Category C, in a phased approach. Introduction of [...]

The post Drug Tariff Category H announcement appeared first on Community Pharmacy England.

Date issued: 5 January 2026 FSA Ref: FSA-PRIN-02-2026 Nestlé has issued a precautionary recall for several SMA infant and follow‑on formula products, due to potential contamination with cereulide toxin—a heat‑stable toxin produced by Bacillus cereus. Affected Products Pharmacy teams should review their stock for the following products and batch codes: SMA Advanced First Infant Milk [...]

The post FSA recall: SMA Infant and Follow‑On Formula (Nestlé) appeared first on Community Pharmacy England.